Endpoints for lymphatic filariasis programs.

Caroline A. Grady,Madsen Beau de Rochars,Abdel N. Direny,Jean Nicolas Orelus,Joyanna Wendt,Jeanne Radday,Els Mathieu,Jacquelin M. Roberts,Thomas G. Streit,David G. Addiss,Patrick J. Lammie

EMERGING INFECTIOUS DISEASES（2007）

引用 34|浏览17

暂无评分

摘要

In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.

查看译文

关键词

prevalence,program evaluation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要